Testing effectiveness (Phase 2)Study completedNCT03134222
What this trial is testing
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
Who this might be right for
Cutaneous Lupus Erythematosus
Gilead Sciences 47